JP2022517117A5 - - Google Patents
Info
- Publication number
- JP2022517117A5 JP2022517117A5 JP2021540587A JP2021540587A JP2022517117A5 JP 2022517117 A5 JP2022517117 A5 JP 2022517117A5 JP 2021540587 A JP2021540587 A JP 2021540587A JP 2021540587 A JP2021540587 A JP 2021540587A JP 2022517117 A5 JP2022517117 A5 JP 2022517117A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962792276P | 2019-01-14 | 2019-01-14 | |
| US62/792,276 | 2019-01-14 | ||
| PCT/US2020/013581 WO2020150290A2 (en) | 2019-01-14 | 2020-01-14 | Methods and compositions for restoring stmn2 levels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517117A JP2022517117A (ja) | 2022-03-04 |
| JP2022517117A5 true JP2022517117A5 (https=) | 2023-01-25 |
| JPWO2020150290A5 JPWO2020150290A5 (https=) | 2023-01-25 |
Family
ID=71613551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540587A Pending JP2022517117A (ja) | 2019-01-14 | 2020-01-14 | Ｓｔｍｎ２レベルを回復させるための方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12496327B2 (https=) |
| EP (1) | EP3911411A4 (https=) |
| JP (1) | JP2022517117A (https=) |
| CN (1) | CN114173821A (https=) |
| CA (1) | CA3126918A1 (https=) |
| WO (1) | WO2020150290A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3103429A1 (en) | 2018-06-14 | 2019-12-19 | Don W. Cleveland | Compounds and methods for increasing stmn2 expression |
| EP4162051A4 (en) * | 2020-06-03 | 2025-07-09 | Quralis Corp | TREATMENT OF NEUROLOGICAL DISEASES USING GENE TRANSCRIPT MODULATORS |
| WO2022018155A1 (en) * | 2020-07-23 | 2022-01-27 | F. Hoffmann-La Roche Ag | Lna oligonucleotides for splice modulation of stmn2 |
| US20250270548A1 (en) * | 2020-12-07 | 2025-08-28 | Perron Institute for Neurological and Translational Science Limited | Compositions and methods for treating tardbp associated diseases |
| CA3215808A1 (en) * | 2021-04-22 | 2022-10-27 | Roger Chung | Modified polypeptides and uses thereof |
| KR20240052763A (ko) * | 2021-08-11 | 2024-04-23 | 아버 바이오테크놀로지스, 인크. | 스타스민 2 (stmn2)를 표적화하는 rna 가이드를 포함하는 유전자 편집 시스템 및 이의 용도 |
| AU2022402929A1 (en) * | 2021-12-03 | 2024-06-13 | Quralis Corporation | Splice switcher antisense oligonucleotides with modified backbone chemistries |
| EP4724426A1 (en) * | 2023-06-12 | 2026-04-15 | The General Hospital Corporation | Statin derivatives and methods of using the same |
| WO2025076126A1 (en) * | 2023-10-02 | 2025-04-10 | Emory University | Agents that bind nucleic acids encoding elavl3 cryptic exons, pharmaceutical compositions, and uses in managing neurological diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1815863A1 (en) * | 2006-02-03 | 2007-08-08 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Use of TLR3 agonists for the treatment of neurodegenerative disorders |
| CA2653974A1 (en) | 2006-05-30 | 2008-02-14 | Mayo Foundation For Medical Education And Research | Detecting and treating dementia |
| WO2013169793A2 (en) * | 2012-05-09 | 2013-11-14 | Ipierian, Inc. | Methods and compositions for tdp-43 proteinopathies |
| US9612534B2 (en) * | 2015-03-31 | 2017-04-04 | Tokyo Electron Limited | Exposure dose homogenization through rotation, translation, and variable processing conditions |
| GB201703123D0 (en) * | 2017-02-27 | 2017-04-12 | St George's Hospital Medical School | Biomarkers |
| CA3103429A1 (en) | 2018-06-14 | 2019-12-19 | Don W. Cleveland | Compounds and methods for increasing stmn2 expression |
| JP7795914B2 (ja) | 2019-06-03 | 2026-01-08 | クラリス コーポレーション | 神経学的疾患を処置するためのオリゴヌクレオチドおよびその使用方法 |
| EP4127172A4 (en) | 2020-03-25 | 2025-06-04 | President and Fellows of Harvard College | Methods and compositions for restoring STMN2 levels |
-
2020
- 2020-01-14 WO PCT/US2020/013581 patent/WO2020150290A2/en not_active Ceased
- 2020-01-14 US US17/423,104 patent/US12496327B2/en active Active
- 2020-01-14 EP EP20740861.8A patent/EP3911411A4/en active Pending
- 2020-01-14 CN CN202080020187.5A patent/CN114173821A/zh active Pending
- 2020-01-14 CA CA3126918A patent/CA3126918A1/en active Pending
- 2020-01-14 JP JP2021540587A patent/JP2022517117A/ja active Pending